{"text": ["Glancy", "Prongay", "&", "Murray", "LLP", "Continues", "its", "Investigation", "on", "Behalf", "of", "Novartis", "AG", "Investors", "(NVS)"], "created_at": "2019-09-11 20:30:00"}
{"text": ["Leaner", "Pfizer", "Positioned", "to", "Boost", "R&D", "Output"], "created_at": "2019-09-11 19:50:48"}
{"text": ["Pharma", "Stock", "Calls", "Could", "Double", "Fast"], "created_at": "2019-09-11 18:03:45"}
{"text": ["INVESTOR", "ALERT:", "Law", "Offices", "of", "Howard", "G.", "Smith", "Continues", "its", "Investigation", "on", "Behalf", "of", "Novartis", "AG", "Investors", "(NVS)"], "created_at": "2019-09-11 17:44:30"}
{"text": ["Why", "Amgen", "Stock", "Perked", "Up", "Last", "Month"], "created_at": "2019-09-11 15:53:24"}
{"text": ["Why", "Amgen", "Stock", "Perked", "Up", "Last", "Month"], "created_at": "2019-09-11 15:53:24"}
{"text": ["4", "Big", "Drugmakers", "Boasting", "Impressive", "Oncology", "Pipelines"], "created_at": "2019-09-11 13:32:01"}
{"text": ["ONGOING", "INVESTIGATION", "ALERT:", "The", "Schall", "Law", "Firm", "Announces", "it", "is", "Investigating", "Claims", "Against", "Novartis", "AG", "and", "Encourages", "Investors", "with", "Losses", "in", "Excess", "of", "$100,000", "to", "Contact", "the", "Firm"], "created_at": "2019-09-11 13:28:52"}
{"text": ["Allergan's", "Filings", "for", "Abicipar", "Pegol", "Accepted", "in", "U.S/Europe"], "created_at": "2019-09-11 12:35:26"}
{"text": ["Allergan's", "Filings", "for", "Abicipar", "Pegol", "Accepted", "in", "U.S/Europe"], "created_at": "2019-09-11 12:35:26"}
{"text": ["Allergan's", "Filings", "for", "Abicipar", "Pegol", "Accepted", "in", "U.S/Europe"], "created_at": "2019-09-11 10:01:10"}
